Artificial intelligence-powered patient engagement and payments platform Weave will be bought by global investment firm Francisco Partners for about $650 million.
Under the terms of the deal, Weave stockholders will receive $7.40 per share in cash, representing a premium of approximately 34% to Weave’s unaffected closing stock price on August 17, 2026, the last full trading day prior to the transaction announcement.
The company will continue to operate under the Weave name and maintain its headquarters in Lehi, UT. The deal is expected to close in the fourth quarter of 2026.
